National Summit on Quality in General Practice

I attended the National Summit on Quality in General Practice on 31 July 2014, which was held at the RCGP Headquarters in Central London. The event was organised by the RCGP, the Health Foundation, and the BMJ. Among the attendees were Dr Maureen Baker, Chair of the RCGP, Dr Fiona Godlee, Editor of the BMJ, and Dr Richard Vautrey from the BMA's General Practice Committee. The National Summit was facilitated by Judy Oliver.

At the meeting, there were presentations and discussion on the current state of general practice in the UK, the challenges we need to overcome to provide high quality primary care services, the importance of adopting a patient-centred approach in the measurement of quality of care, and how we can make change happen in the current political and economic contexts. Delegates worked in groups to address these issues.

Amongst my group were Anna Damerell, Richard Vautrey, Bryan Fisher, Nick Steele and Tom Duncan.We had a stimulating debate on the many challenges facing general practice - such as a rising volume and increased complexity of workload, reduced funding for general practice, dealing with multi-morbidity, and continuing to provide an accessible and high-quality primary care services.

Dr Fiona Godlee, Editor of the BMJ, speaks about promoting research and innovation in general practice.

Comments

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...

Medical Centre

Search This Blog